Lacerta Therapeutics


President and CEO

Dr. Edgardo Rodriguez-Lebron is one of Lacerta’s co-founders and has actively guided Lacerta as scientific advisor, Chief Scientific Officer, Chairman of the Board and now Chief Executive Officer.

Dr. Rodriguez-Lebron brings over two decades of research experience and entrepreneurial leadership to Lacerta. His research on Huntington’s disease, spinocerebellar ataxias and other neurodegenerative diseases has been funded by the NIH and multiple foundations. He has also secured tens of millions of dollars in non-dilutive funds to fuel Lacerta’s growth and commitment to finding a cure for rare CNS diseases. His ongoing affiliation with the University of Florida keeps him on the cutting edge of scientific discoveries.

Dr. Rodriguez-Lebron holds multiple patents in AAV technology and degrees in Molecular Biology from the University of Central Florida and a Ph.D. in Neuroscience from the University of Florida. An active contributor to the gene therapy community, he is an ASGCT member and serves as the CSO of NF2Biosolutions, a nonprofit focused on the development of a gene therapy approach to neurofibromatosis type 2 (NF2). He has co-founded and helped launch multiple startups in the Gainesville, Florida area. A Florida Gator at heart and by degree, Dr. Rodriguez-Lebron can be found cheering on the home team most fall weekends.